Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice
Colloids and Surfaces B: Biointerfaces · 2024
DOI: 10.1016/j.colsurfb.2024.113992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2024. Verfasst von Qiuyue Jin und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanxi Medical University, Taiyuan 030001, China. Hauptthemen laut MEDLINE: Artemisinins, Doxorubicin, Prodrugs, Liposomes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
In order to reduce the cardiotoxicity of doxorubicin (DOX) and improve its antitumor effect, dihydroartemisinin (DHA) and DOX prodrug (DOX-S-DHA) synthesized via a single sulfur bond was used with TEPP-46 to prepare nano-liposomes (DOX-S-DHA@TEPP-46 Lips). In which, TEPP-46 was expected to exert p53 bidirectional regulation to promote the synergistic antitumor effect of DOX and DHA while reducing cardiotoxicity. DOX-S-DHA@TEPP-46 Lips exhibited uniform particle size, good stability, and excellent redox-responsive activity. DOX-S-DHA@TEPP-46 Lips could significantly inhibit the proliferation of tumor cells, but had less cytotoxicity on normal cells. The presence of TEPP-46 increased the content of p53 protein, which further induced tumor cell apoptosis. DOX-S-DHA@TEPP-46 Lips had satisfactory long circulation to enhance the antitumor efficacy and reversed the cardiotoxicity of DOX in B16-F10 tumor-bearing mice. In conclusion, DOX-S-DHA@TEPP-46 Lips provides a new insight on creating sophisticated redox-sensitive nano-liposomes for cancer therapy as well as the decreased cardiotoxicity of DOX.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shanxi Medical University, Taiyuan 030001, China.
- Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China.
- School of Pharmacy, Shanxi Medical University, Taiyuan 030001, China; Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China; Shanxi…
Zitieren
APA
Jin, Q., Zhou, X., Niu, X., Ping, C., Dong, X., Duan, D., Wang, R., Chen, Y., Pan, F., Yang, F., Yang, X., Zhang, G., Wang, R., Zhang, S., & Ren, G. (2024). Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2024.113992
Vancouver
Jin Q, Zhou X, Niu X, Ping C, Dong X, Duan D, et al. Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice. Colloids and Surfaces B: Biointerfaces. 2024. doi:10.1016/j.colsurfb.2024.113992
BibTeX
@article{Jin2024,
author = {Jin, Qiuyue and Zhou, Xiaohui and Niu, Xiaomin and Ping, Canqi and Dong, Xiaozhou and Duan, Danyu and Wang, Rongrong and Chen, Yi and Pan, Fei and Yang, Fan and Yang, Xihua and Zhang, Guoshun and Wang, Ruili and Zhang, Shuqiu and Ren, Guolian},
title = {Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2024},
doi = {10.1016/j.colsurfb.2024.113992}
}
EUVIMED